Development of FTO-specific inhibitors from natural phytochemicals is a promising strategy to avoid the side effects of synthetic drugs for treatment of obesity and other chronic diseases (146). This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.